Daya Ventures closes pre-seed round
The Swedish-based Venture Studio supports the development of user-centric women's health and technology solutions in its ‘Daya Innovation Lab’.
Swedish-based Daya Ventures, a global venture studio which helps foster FemTech innovation, has proudly announced the successful closing of its pre-seed investment round.
The round was led by Nextblue, an international VC fund renowned for backing pioneering startups in Europe and Japan.
Daya, headquartered in Gothenburg, supports the development of user-centric women's health and technology solutions in its ‘Daya Innovation Lab’. It works with entrepreneurs and also builds its own solutions. Projects include Otii, an automated breastfeeding monitor; Essa, a tool for perineal massage; Neblina, a unified data platform; Daya Cos, toxin-free skincare products; Vilma, a mental health companion app; and Juno, a non-invasive wearable for detecting preeclampsia.
Vincent Tan, Partner at Nextblue said:
"We invested in Daya because they are pioneering femtech innovation in the Nordics, addressing the long-overlooked needs of women's health. Daya’s interdisciplinary approach, combining technology, design, and healthcare, promises to create impactful solutions for female health and wellbeing.
“Their vision aligns with our commitment to support ventures that drive inclusive healthcare and empower women globally."
Additional investors in this round include Vera Invest, Peter Strömberg (ex-Avanza), and key members of the Daya team.
Peter Strömberg said:
"For me, investing in Daya is a commitment to leveling the healthcare playing field. By supporting femtech innovation, Daya represents a crucial stride towards ensuring every innovation not only advances in technology but uplifts the health and wellbeing of women globally."
CEO of Daya Ventures Malin Frithiofsson said:
"We are thrilled to have the support of such esteemed investors. This funding will allow us to expand our portfolio by taking several new ideas from concept to incorporation in our Innovation Lab, accelerating our mission to transform women's health."